D.C. Mun. Regs. tit. 22, r. 22-B202

Current through Register Vol. 71, No. 49, December 6, 2024
Rule 22-B202 - REPORTING OCCURRENCES
202.1

The physician, veterinarian, or other person in charge of a communicable disease case shall report the case to the Director within the period of time required and in the manner prescribed in § 201.

202.2

In the report required in § 202.1, the physician, veterinarian, or other person in charge of the case shall include a statement of the person's instructions concerning isolation, restriction of movement, and quarantine in detail. The statement may be limited to stating that the instructions were in accordance with the provisions of this chapter and with the latest edition of "Control of Communicable Diseases Manual", published by the American Public Health Association.

202.3

A physician, veterinarian, or other person having information of a carrier or contact shall report that information to the Director.

202.4

Each infected adult person, and each parent, guardian, or person in charge of an infected person or animal shall be advised by the physician, veterinarian, or other person in charge, of the applicable requirements for isolation, restriction of movement, and quarantine.

202.5

The physician or other person in charge of a communicable disease case involving a human being shall advise each infected adult person and parent, guardian, or other individual having responsibility for isolation and quarantine.

202.6

The veterinarian or other person in charge of a communicable disease case involving an infected animal shall advise the individual having responsibility for the care of the animal of the applicable requirements for isolation and quarantine.

202.7

The control and management of any carrier, contact, or infected person or animal shall be in accordance with good medical and public health practice.

202.8

Meeting the requirements of this section and observance of the provisions of the latest edition of "Control of Communicable Diseases Manual", published by the American Public Health Association, shall be prima facie evidence that the control and management of any carrier, contact, or infected person or animal has been in accordance with good medical and public health practice.

202.9

When reporting to the Department, the report shall be filed on a form approved by the Director, and the following information shall be furnished as completely as possible:

(a) Information regarding the person submitting the report, including first and last name, phone number, facility name, facility address, name of the provider who saw the patient, and the date the report was sent;
(b) Patient information, including first and last name, date of birth, gender, home address, race or ethnicity, telephone number, and school or place of occupation;
(c) Disease, condition, or symptom information, including the name of the suspected or confirmed disease, date of symptom onset, date of diagnosis, and supporting laboratory documentation; and
(d) Other epidemiologic information the Director may request.
202.10

Any physician treating or caring for a person with a communicable disease shall report immediately the name, address, and other relevant information to the Director under the following circumstances:

(a) When the person is delinquent in treatment;
(b) When the person violates isolation or quarantine; or
(c) When there is any change of location of the case.
202.11

When making a written report of a communicable disease or when confirming a telephone report in writing, the following information shall be furnished:

(a) Location of the case;
(b) Patient's name, home address, telephone number, age, sex, color, and school or place of occupation;
(c) Name of physician or other person in charge;
(d) Name of laboratory;
(e) Diagnosis of disease;
(f) Time of onset;
(g) Name of hospital, if admitted, and time of admission; and
(h) Other pertinent information.
202.12

Any change in the location of a case shall be reported to the Director by phone or in writing within twenty-four (24) hours of the change.

202.13

In addition to the reporting required by subsections 202.1 through 202.12, the Public Health Laboratory shall report within twenty-four (24) hours after completion of each test result each positive or negative SARS-CoV-2 test result to the District of Columbia Health Information Exchange established by Chapter 87 of Title 29 of the District of Columbia Municipal Regulations.

202.14

In addition to the reporting required by subsections 202.1 through 202.12, each clinical laboratory operating in the District of Columbia, a clinical laboratory providing services to a health care facility located in the District of Columbia, or a clinical laboratory providing services to a health care provider located in the District of Columbia shall report each positive or negative SARS-CoV-2 test result to the District of Columbia Health Information Exchange established by Chapter 87 of Title 29 of the District of Columbia Municipal Regulations.

D.C. Mun. Regs. tit. 22, r. 22-B202

Commissioners' Order 61-1117 (June 20, 1961), 8 DCRR §§8 -5:105 and 8-5:106 (1965); as amended by Final Rulemaking published at 55 DCR 5980 (May 23, 2008); amended by Final Rulemaking published at 63 DCR 015116 (12/9/2016); amended by Final Rulemaking published at 68 DCR 11091 (10/22/2021)